Neuronal atrophy early in a mouse model of spinal cerebellar ataxia 1 may represent an adaptive mechanism that restores the density of potassium channels in Purkinje neurons, thus normalizing ...

There is currently no cure for Friedreich’s ataxia. Treatment focuses on managing your symptoms and improving your quality of life to help you maintain your daily function and activities as long ...

Panelists discuss how the differential diagnosis for Friedreich's Ataxia involves distinguishing it from other ataxias, the process of definitive diagnosis through genetic testing, and the ...

While there isn't currently a cure for this condition, treatments like medications and therapies can help improve cerebral palsy symptoms. Types of Cerebral Palsy Cerebral palsy can affect a ...

can increase the risk your baby will be born with cerebral palsy. They include: Although there’s no cure for CP, there are many treatments that can help you live your best life. These treatments ...

secondary cerebral vasculitis (which can occur in connective-tissue diseases), systemic vasculitis, and infections. Early recognition is important because treatment with glucocorticoids with or ...

SIADH (syndrome of inappropriate antidiuretic hormone secretion) leads to hyponatremia water retention in hospitalized or ...

How to Choose the Best Hair Loss Treatment for You Finding the right hair loss treatment depends on the type and severity of your hair loss. With so many options available, it’s important to ...

These treatment benefits translate into a ... subjects from the US Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA) in accordance with FDA's Guidance on Real-World ...

Researchers have discovered that the protein mutated in Huntington’s Disease fails to properly repair DNA, leading to reduced brain cell healing.

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), today announced positive topline results from pivotal Study BHV4157-206-RWE (NCT06529146) demonstrating the efficacy of troriluzole on the mean ...

With NLX-112, we are making strides in the field of movement disorders, including Spinocerebellar Ataxia, and this designation further solidifies our commitment to advancing treatments for rare ...